News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
Top Breaking News
Bruker Corporation Discloses Plans To Sell California Unit And Lay Off Up To 250     7/25/2014
Reckitt Benckiser Plc (RB.L) To Invest €100 Million In Its Consumer Health R&D Operations, Will Create 1,200 New Jobs     7/25/2014
New Cambridge-Based Biotech VC Firm, Remiges BioPharma, Eyes $150 Million Fund     7/25/2014
Bayer HealthCare (BAY), Amgen (AMGN)'s Nexavar Fails Late-Stage Breast Cancer Study     7/25/2014
Sources Reveal Reckitt Benckiser Plc (RB.L) Plans To Spinoff Virginia-Based Pharmaceutical Unit     7/25/2014
Merck KGaA (MKGAF.PK) Eyes Southeast Asia Plants To Cut Costs     7/25/2014
Allegations Of GlaxoSmithKline (GSK) Corruption Spread To Syria     7/25/2014
Incyte Corporation (INCY)'s Jakafi Fails to Provide RELIEF In Phase 3 Trial     7/25/2014
AgeneBio Appoints Industry Leaders Patrick Lepore As Chairman Of The Board And Jerry Mclaughlin As President And Chief Executive Officer     7/25/2014
Amgen (AMGN) Nervous As FDA Paves Way For Novartis AG (NVS) To Copy Drug Neupogen     7/24/2014
Sarepta Therapeutics (SRPT) Terminates Chief Science Officer As It Heads Toward Drug Approval     7/24/2014
San Diego Biotech Pfenex Inc. (PFNX) Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation     7/24/2014
Seattle Biotech Immune Design Corporation (IMDZ) Prices IPO At $12 Per Share, The Low End Of The Range     7/24/2014
Study Claims Celgene (CELG) Drug Can Drive HIV Out Of Hiding     7/24/2014
Bay Area's Intersect ENT Secures $55 Million After Hitting The Low End Of Its IPO Range     7/24/2014

Featured Stories
Chairwoman Reveals How AbbVie (ABBV) Wooed Shire With Its Inversion Scheme     7/25/2014
Research Led By Temple University School Of Medicine's Chair Of Dermatology Shows That Pain And Itch May Be Signs Of Skin Cancer     7/25/2014
Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study     7/25/2014
The Ingredients Of "All Natural Foods" Will Terrify You     7/25/2014
4 Ways Gilead Sciences, Inc. (GILD)’s Earnings Will Impact Every American     7/24/2014
What You Need To Know About The Listeria Fruit Recall     7/24/2014
Do Drugmakers Use An FDA Safety Program To Thwart Generics?     7/24/2014
Paracetamol Does Not Work For Lower Back Pain, University of Sydney Study     7/24/2014
More U.S. Teens' Report Using Human Growth Hormone     7/24/2014
Indian Boy Has 232 Teeth Removed     7/24/2014
Rosemary And Oregano Contain Diabetes-Fighting Compounds, Agricultural And Food Chemistry Reveals     7/24/2014
Where Are The Unhappiest Cities In America? University of British Columbia Study     7/24/2014
Centers for Disease Control and Prevention (CDC) Says Lab Director Behind Anthrax Mishap Resigns     7/24/2014
Poland Confirms Case Of African Swine Fever In Farm Pigs, World Organization for Animal Health Reveal     7/24/2014
3 Quotes From Johnson & Johnson (JNJ)'s Conference Call You Need To Read     7/23/2014

More News
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: PLEGRIDY™ (Peginterferon beta-1a) Approved In The European Union For The Treatment Of Multiple Sclerosis     7/24/2014
Alexion Pharmaceuticals Inc. (ALXN) Release: European Medicines Agency Accepts Marketing Authorization Application For Asfotase Alfa As A Treatment For Patients With Hypophosphatasia     7/24/2014
Bayer HealthCare AG (BAY) Release: Phase 3 Investigational Trial Of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints In Subjects With Papulopustular Rosacea     7/24/2014
Merck & Co., Inc. (MRK) Initiates Phase 3 Study Of Letermovir, An Investigational Antiviral For Prevention Of Cytomegalovirus (CMV) Infection In High-Risk Bone Marrow Transplant Patients     7/24/2014
rEVO Biologics Announces Enrollment Of First Patient In Phase 3 Trial Of Atryn® To Treat Early Onset Preeclampsia (PRESERVE-1)     7/24/2014
Aerie Pharmaceuticals, Inc. (AERI) Receives Health Canada "No Objection Letter" To Commence Phase 3 Registration Trial Of Rhopressatm In Patients With Glaucoma In Canada     7/24/2014
Alios BioPharma Reports Positive Results Of Its Anti-RSV Nucleoside Analog AL-8176 In A Phase 2 Challenge Study In Adults Infected With Respiratory Syncytial Virus (RSV)     7/24/2014
Esperion Therapeutics, Inc. (ESPR) Announces Initiation Of A Phase 2 Clinical Study Of ETC-1002 In Patients With Hypercholesterolemia And Hypertension     7/24/2014
Media Advisory: AFFiRiS AG Presents Early Clinical Data On A First-Of-Its-Kind Parkinson's Disease Vaccine     7/24/2014
Advanced Biologics Publishes Additional Osteoamp® Abstracts In The Bone And Joint Journal     7/24/2014
Bavarian Nordic (BAVA.CO) Announces First Patient Treated In A Phase 1 Study Of MVA-BN® Brachyury In Advanced Cancer     7/24/2014
Amunix, Inc. And PolyPeptide Publish Multivalent Antiviral XTEN-Peptide Conjugates In Vivo Studies In American Chemical Society's Journal     7/24/2014
Kinex Pharmaceuticals Announces Allowance Of The Investigational New Drug (IND) Application For KX2-391 Ointment By The United States FDA     7/24/2014
Geisinger Health System Study: Overweight Boys May Benefit From Living With Adult Who Has Bariatric Surgery     7/24/2014
NPS Pharmaceuticals, Inc. (NPSP) Release: PARADOX Findings Published In Endocrine Practice Describe High Burden Of Illness In Patients With Hypoparathyroidism     7/24/2014
TCGA Researchers Identify Four Subtypes Of Stomach Cancer     7/24/2014
Bioheart, Inc. Announces World's First Combination Stem Cell Treatment     7/24/2014
ProPhase LLC Scientists Publish New Article Detailing Evolution Of Illness Phases In Schizophrenia     7/24/2014
WIRB-Copernicus Group Announces Acquisition Of Alliance Biosciences; Executives Join WCG Biosafety Division     7/24/2014
Simulations Plus (SLP) To Acquire Cognigen Corporation     7/24/2014
Bristol-Myers Squibb Company (BMY) And Ono Pharmaceutical Company, Ltd. Announce Strategic Immuno-Oncology Collaboration In Japan, South Korea And Taiwan     7/24/2014
Evogene Ltd. (EVGN) Announces Amendment To Bayer Wheat Agreement To Focus On Discovery Of Novel Genomic Promoters     7/24/2014
Cipher Pharmaceuticals (DND.TO) And Ranbaxy Laboratories (RANBAXY.BO) Announce Distribution Agreement For Isotretinoin Product In Brazil     7/24/2014
TransCelerate BioPharma Selects Cognizant (CTSH) To Develop A Clinical Trials Collaboration Platform     7/24/2014
Immune Pharmaceuticals, Inc. Release: Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin     7/24/2014
LSI Medience Corporation And Kineticos Sign Agreement Related To The Presepsin Biomarker In Sepsis Management And Treatment     7/24/2014
Agilent Technologies Inc. (A) Signs Co-Marketing Agreement With MRM Proteomics To Advance Quantitative Proteomics Solutions     7/24/2014
Taconic Announces New Agreement To Distribute Next Generation NOG Mouse Models     7/24/2014
Clinical Study With BioTie Therapies Corp.''s BTT1023 In Primary Sclerosing Cholangitis Awarded External Grant Funding     7/24/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States     7/24/2014
Abbott Introduces New Similac® Breastfeeding Supplement With DHA, Lutein And Vitamin E     7/24/2014
MYOS (MYOS) Receives Notice Of Allowance Of U.S. Patent Application For Proprietary Manufacturing Methods Of Fortetropin     7/24/2014
Boehringer Ingelheim Corporation Release: Benefits And Safety Of Pradaxa® (Dabigatran Etexilate Mesylate) Repeatedly Confirmed     7/24/2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014     7/24/2014
Xention Limited Awarded £1.4m From Technology Strategy Board To Develop New Medicines For Atrial Fibrillation     7/24/2014
Sigma-Aldrich Corporation (SIAL) (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted Eps Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted Eps Guidance To A New Range Of $4.32 To $4.40     7/24/2014
CorMedix (CRMD) Granted Extension Of NYSE-MKT Listing     7/24/2014
Allied Minds Announces Completion Of Its Initial Public Offering And Admission To The London Stock Exchange     7/24/2014
MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe     7/24/2014
BioAlliance Pharma: Approval Of Onxeo’s Admission To Secondary Listing And Trading On NASDAQ OMX Copenhagen     7/24/2014
Pulmonary Fibrosis Foundation Launches National PFF Ambassador Program     7/24/2014
Admedus Increases Stake In Ian Frazer’s Vaccines     7/24/2014
Nutra Pharma Corp. (NPHC) Announces Infrastructure Improvements To Handle Increased Sales     7/24/2014
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track     7/24/2014
Allergy Therapeutics plc Release: Notice Of Results And Trading Update     7/24/2014
Spherix (SPEX) Schedules Shareholder Update Call     7/24/2014
Charles River Laboratories (Massachusetts) To Webcast Investor Meeting     7/24/2014
Merck & Co., Inc. (MRK) Announces Fourth-Quarter 2014 Dividend     7/24/2014
PHT Corporation Reports Record Breaking 2nd Quarter As Pharma Industry Champions Patient-Driven eData Systems In Clinical Research     7/24/2014
BASF Increases Prices For Ethanolamines In Europe     7/24/2014
Bioheart, Inc. Announces World's First Combination Stem Cell Treatment     7/24/2014
TapImmune Inc. (TPIV) Prevails In Legal Dispute With Michael Gardner     7/24/2014
Valeant Pharmaceuticals International (VRX) Files An Official Complaint With The Autorite Des Marches Financiers About Allergan Inc. (AGN)'s False And Misleading Statements     7/24/2014
Agenus (AGEN) Release: First Vaccine Candidate for Malaria is Accepted for EU Regulatory Review     7/24/2014
Agenus (AGEN) Reports Second Quarter 2014 Financial Results     7/24/2014
AmerisourceBergen Corporation (ABC) Reports Third Quarter Fiscal Year 2014 Results     7/24/2014
Alexion Pharmaceuticals Inc. (ALXN) Reports Second Quarter 2014 Results     7/24/2014
Acorda Therapeutics (ACOR) To Host Conference Call To Discuss Second Quarter 2014 Financial Results On July 31, 2014     7/24/2014
Adocia Reports Operational And Financial Results For The First Half Of 2014     7/24/2014
BIND Therapeutics (BIND) To Report Second Quarter 2014 Financial Results On August 7, 2014     7/24/2014
BioInvent (BOVNF) Interim Report 1 January – 30 June 2014     7/24/2014
Bristol-Myers Squibb Company (BMY) Reports Second Quarter 2014 Financial Results     7/24/2014
Beximco Pharmaceuticals Half Year Results - 2014     7/24/2014
Centene Corporation Reports 2014 Second Quarter Results & Raises Guidance     7/24/2014
Celgene (CELG) Reports Second Quarter 2014 Operating and Financial Results     7/24/2014
Clinigen Group Release: Year End Trading Update     7/24/2014
Eli Lilly and Company (LLY) Reports Second-Quarter 2014 Results     7/24/2014
Gilead Sciences, Inc. (GILD) Announces Second Quarter 2014 Financial Results     7/24/2014
Infinity Pharmaceuticals Inc. (INFI) Announces The Date Of Its Second Quarter 2014 Financial Results Conference Call And Webcast     7/24/2014
IMS Health Reports Second-Quarter 2014 Results     7/24/2014
Meridian Bioscience, Inc. (VIVO) Reports Third Quarter And Nine Months Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2014 Guidance     7/24/2014
OncoGenex Pharmaceuticals Inc. (OGXI) To Report Financial Results For Second Quarter 2014 On August 7, 2014     7/24/2014
OXiGENE (OXGN) Announces Second Quarter 2014 Earnings Conference Call And Webcast     7/24/2014
Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Reports Record Second Quarter Financial Results     7/24/2014
Salix Pharmaceuticals, Ltd. (SLXP) Announces 2Q2014 Financial Results Conference Call And Webcast     7/24/2014
Sangamo BioSciences, Inc. (SGMO) Reports Second Quarter 2014 Financial Results     7/24/2014
Utah Medical Products, Inc. (UTMD) Reports Financial Performance For Second Quarter 2014     7/24/2014
Vical Incorporated (VICL) Announces News Release And Conference Call Schedule For Second Quarter 2014 Financial Results     7/24/2014
West Pharmaceutical Services To Host Second Quarter 2014 Conference Call     7/24/2014
Xencor To Host Second Quarter 2014 Financial Results Webcast And Conference Call     7/24/2014
Cypher Genomics Announces The Appointment Of Adam Simpson As President And COO To Advance Transformative Genome Interpretation Technology     7/24/2014
Cypher Genomics Appoints To The Board Of Directors, Henry Nordhoff As Executive Chairman And Herbert Boyer And Andrew Von Eschenbach As Directors     7/24/2014
Cannabis Science Inc. Appoints Dr. Roscoe M. Moore Jr., US Assistant Surgeon General (Retired) For A Second Term On The Scientific Advisory Board As Special Senior Advisor To The Company     7/24/2014
Flexion Therapeutics (FLXN) Announces Board Changes     7/24/2014
GliaCure Appoints New Member To Board Of Directors     7/24/2014
Juventas Therapeutics, Inc. Strengthens Leadership Team By Adding Two Industry Veterans     7/24/2014
Protalix Biotherapeutics, Inc. (PLX) Names Shlomo Yanai As Chairman Of The Board Of Directors     7/24/2014
The Leukemia & Lymphoma Society Applauds FDA's Approval Of Idelalisib To Treat Three Types Of Blood Cancers     7/24/2014
In RadioMD Interview, Dr. John Crew Describes Successful New Treatment For Flesh-Eating Disease     7/24/2014
Mettler-Toledo (MTD) Release: New Online Selection Tool Helps Customers Find The Perfect Laboratory Balances And Scales With Just A Few Clicks Of their Mouse     7/24/2014
GlaxoSmithKline (GSK) CEO And CFO Interviewed On Q2 2014 Results And Strategy Update     7/24/2014
Neogen Corporation (NEOG) Comments On SenesTech     7/24/2014
Surpass, Inc. Launches New Company Logo And Corporate Website, Symbolizing Transformation Of Company Culture To Meet The Changing Needs Of Clients In The Life Science Community Today     7/24/2014
TrialNetworks, Part Of DrugDev, Named A Finalist For The Massachusetts Technology Leadership Healthcare & Life Sciences Innovation Award     7/24/2014
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Announces Accepted Abstracts At The 2014 Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC)     7/24/2014
Acasti Pharma Announces Oral Presentation On COLT Study Results At 19th World Congress On Heart Disease In Boston     7/24/2014
Imprimis Pharmaceuticals (immy)' Go Dropless™ Cataract Surgery Formulations To Be Featured In Two Sessions At The 2014 American-European Congress Of Ophthalmic Surgery (AECOS) Summer Symposium     7/24/2014
AFFiRiS AG Presents Early Clinical Data On A First-Of-Its-Kind Parkinson's Disease Vaccine     7/24/2014
Dotmatics Announce Speaker Line-up for User Group Meeting 2014     7/24/2014
Amarantus BioSciences, Inc. And BSI Announce Dr. Thomas Arendt As Presenter At 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit At United Nations     7/24/2014
Compugen Ltd. (CGEN) To Present Immune Checkpoint Related Research At Two Scientific Conferences     7/24/2014
Owens & Minor (OMI) To Host 9th Annual Healthcare Supplier Diversity Symposium On September 23-24, 2014     7/24/2014

Career Tips
Half Of Biotech Employees Dissatisfied With Their Employer     7/24/2014
5 Overused Phrases To Avoid Putting On Your Resume     7/24/2014
9 Proofreading Steps Every Job Seeker Should Follow     7/24/2014
Questions To Never Ask At A Job Interview     7/24/2014
5 Mistakes That Make Your Emails Unprofessional     7/24/2014
Job Seekers: No, The Thank You Email Is Not Dead     7/24/2014
5 Most Promising Biotech Jobs By 2022     7/10/2014
6 Smart Solutions For Customizing Your Resume     7/10/2014
7 Worst Things About Job Interviews     7/10/2014
5 Tips For Standing Out At A New Job (And Fit In Too)     7/10/2014
7 Reasons Your Coworkers Don’t Trust You     7/10/2014
Surprising Things You Didn't Know You Could Negotiate     7/10/2014
Revealed: The Biggest Fears For The Newest Job Seekers     6/26/2014
3 Steps To Enhancing Your Resume In Under 20 Minutes     6/26/2014
5 Ways An Online Reputation Can Hurt Your Job Hunt     6/26/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do

Press Release Submissions
Post your news